National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 63520-63521 [2018-26674]
Download as PDF
<![CDATA[
63520
Federal Register / Vol. 83, No. 236 / Monday, December 10, 2018 / Notices
Minority Health and Health Disparities
Special Emphasis Panel, December 12,
2018 1:00 p.m. to December 12, 2018,
6:00 p.m., National Institutes of Health,
Gateway Building, 7201 Wisconsin
Ave., Suite 533, Bethesda, MD 20814,
which was published in the Federal
Register on October 31, 2018, 83 FR
54758.
The meeting of the Special Emphasis
Panel; RCMI Research Coordinating
Network (RRCN)(U54) has been
cancelled, because the application to be
reviewed, was withdrawn. The meeting
is closed to the public.
Dated: December 4, 2018.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–26670 Filed 12–7–18; 8:45 am]
BILLING CODE 4140–01–P
Dated: December 4, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Urology and
Nephrology Clinical Small Business
Applications.
Date: December 21, 2018.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6706
Democracy Blvd., Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ryan G. Morris, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7015, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, 301–594–4721,
ryan.morris@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
VerDate Sep<11>2014
17:10 Dec 07, 2018
Jkt 247001
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time Sensitive
Obesity and Diabetes Prevention.
Date: January 8, 2019.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
[FR Doc. 2018–26672 Filed 12–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
General Medical Sciences Council.
The meeting will be open to the
public as indicated below, with a short
public comment period at the end.
Attendance is limited by the space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will also be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov).
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with The grant
applications, the disclosure of which
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: January 24–25, 2019.
Closed: January 24, 2019, 9:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Open: January 25, 2019, 8:30 a.m. to 12:00
p.m.
Agenda: For the discussion of program
policies and issues; opening remarks; report
of the Director, NIGMS; and other business
of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D.,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC6200, BETHESDA, MD 20892–
6200, (301) 594–4499, hagana@
nigms.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: December 4, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–26671 Filed 12–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
E:\FR\FM\10DEN1.SGM
10DEN1
Federal Register / Vol. 83, No. 236 / Monday, December 10, 2018 / Notices
meeting of the National Advisory
Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering, NACBIB Council Meeting,
January 2019.
Date: January 23, 2019.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: Report from the Institute Director,
other Institute Staff and Scientific
Presentations.
Place: The William F. Bolger Center,
Franklin Building, Classroom 1, 9600
Newbridge Drive, Potomac, MD 20854.
Closed: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: The William F. Bolger Center,
Franklin Building, Classroom 1, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: David T. George, Ph.D.,
Acting Associate Director, Office of Research
Administration, National Institute of
Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 920,
Bethesda, MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: December 4, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–26674 Filed 12–7–18; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
17:10 Dec 07, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
63521
Dated: December 3, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–26596 Filed 12–7–18; 8:45 am]
National Eye Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, notice
is hereby given of a meeting of the
National Advisory Eye Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Eye Council.
Date: January 11, 2019.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: Following opening remarks by the
Director, NEI, there will be presentations by
the staff of the Institute and discussions
concerning Institute programs.
Place: NIH, National Eye Institute, First
Floor Conference Rooms, 6700B Rockledge
Drive, Bethesda, MD 20817.
Closed: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, National Eye Institute, First
Floor Conference Rooms, 6700B Rockledge
Drive, Bethesda, MD 20817.
Contact Person: Paul A. Sheehy, Ph.D.,
Director, Division of Extramural Affairs,
National Eye Institute, National Institutes of
Health, 5635 Fishers Lane, Suite 12300,
Bethesda, MD 20892, 301–451–2020, ps32h@
nih.gov.
Information is also available on the
Institute’s/Center’s home page:
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: State Opioid Response (SOR)
and Tribal Opioid Response (TOR)
Program Data Collection and
Performance Measurement—NEW
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Treatment (CSAT) is requesting
approval from the Office of Management
and Budget (OMB) for data collection
activities associated with the State
Opioid Response (SOR) and Tribal
Opioid Response (TOR) discretionary
grant programs. Approval of this
information collection will allow
SAMHSA to continue to meet the
Government Performance and Results
Modernization Act of 2010 (GPRMA)
reporting requirements that quantify the
effects and accomplishments of its
discretionary grant programs which are
consistent with OMB guidance.
Information collected through this
request will be used to monitor
performance throughout the grant
period.
There will be up to 359 award
recipients (states, territories, and tribal
entities) in these grant programs.
Grantee-level data will include
information related to naloxone
purchases and distribution. This
grantee-level information will be
collected quarterly.
All funded states/territories and tribal
entities will also be required to collect
and report client-level data on
individuals who are receiving opioid
treatment and/or recovery services to
ensure program goals and objectives are
being met. Client-level data will include
information such as: Demographic
E:\FR\FM\10DEN1.SGM
10DEN1
]]>Agencies
[Federal Register Volume 83, Number 236 (Monday, December 10, 2018)]
[Notices]
[Pages 63520-63521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-26674]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a
[[Page 63521]]
meeting of the National Advisory Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering, NACBIB Council Meeting, January 2019.
Date: January 23, 2019.
Open: 8:30 a.m. to 11:45 a.m.
Agenda: Report from the Institute Director, other Institute
Staff and Scientific Presentations.
Place: The William F. Bolger Center, Franklin Building,
Classroom 1, 9600 Newbridge Drive, Potomac, MD 20854.
Closed: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: The William F. Bolger Center, Franklin Building,
Classroom 1, 9600 Newbridge Drive, Potomac, MD 20854.
Contact Person: David T. George, Ph.D., Acting Associate
Director, Office of Research Administration, National Institute of
Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard,
Room 920, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: December 4, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-26674 Filed 12-7-18; 8:45 am]
BILLING CODE 4140-01-P
